TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Genentech, Inc.
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RED BIOTECHNOLOGY MARKET, BY PRODUCT
6.1. Overview
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Proteins
6.5. Vaccines
6.6. Cell-Based Immunotherapy Products
6.7. Gene Therapy Products
6.8. Cell Therapy Products
6.9. Tissue-Engineered Products
6.10. Stem Cells
6.11. Cell Culture
6.12. Viral Vector
6.13. Enzymes
6.14. Kits and Reagents
6.15. Animal models
6.16. Molecular diagnostics
6.17. Others
7. GLOBAL RED BIOTECHNOLOGY MARKET, BY END USER
7.1. Overview
7.2. Academic Research Institutes
7.3. CMOs & CROs
7.4. Pharmaceutical & Biotechnology Companies
7.5. Others
8. GLOBAL RED BIOTECHNOLOGY MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Red Biotechnology Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Red Biotechnology Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. Amgen Inc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Biogen Inc.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Gilead Sciences, Inc.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Regeneron Pharmaceuticals, Inc.
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Vertex Pharmaceuticals Incorporated
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Novo Nordisk A/S
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Genentech, Inc.
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Moderna, Inc.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. INCYTE CORPORATION
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Alexion Pharmaceuticals, Inc.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RED BIOTECHNOLOGY MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL RED BIOTECHNOLOGY MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 US: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 US: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 CANADA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 CANADA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 ITALY: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 ITALY: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 UK: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 UK: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 JAPAN: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 20 CHINA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 21 INDIA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 INDIA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: RED BIOTECHNOLOGY MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: RED BIOTECHNOLOGY MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RED BIOTECHNOLOGY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RED BIOTECHNOLOGY MARKET
FIGURE 4 GLOBAL RED BIOTECHNOLOGY MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL RED BIOTECHNOLOGY MARKET, SHARE (%), BY END USER, 2023
FIGURE 6 GLOBAL RED BIOTECHNOLOGY MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: RED BIOTECHNOLOGY MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: RED BIOTECHNOLOGY MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: RED BIOTECHNOLOGY MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: RED BIOTECHNOLOGY MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL RED BIOTECHNOLOGY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 AMGEN INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 AMGEN INC.: SWOT ANALYSIS
FIGURE 14 BIOGEN INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BIOGEN INC.: SWOT ANALYSIS
FIGURE 16 GILEAD SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 GILEAD SCIENCES, INC.: SWOT ANALYSIS
FIGURE 18 REGENERON PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 REGENERON PHARMACEUTICALS, INC.: SWOT ANALYSIS
FIGURE 20 VERTEX PHARMACEUTICALS INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 VERTEX PHARMACEUTICALS INCORPORATED: SWOT ANALYSIS
FIGURE 22 NOVO NORDISK A/S: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 NOVO NORDISK A/S: SWOT ANALYSIS
FIGURE 24 GENENTECH, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 GENENTECH, INC.: SWOT ANALYSIS
FIGURE 26 MODERNA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MODERNA, INC.: SWOT ANALYSIS
FIGURE 28 INCYTE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INCYTE CORPORATION: SWOT ANALYSIS
FIGURE 30 ALEXION PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ALEXION PHARMACEUTICALS, INC.: SWOT ANALYSIS
